(19)
(11) EP 4 240 174 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.10.2024 Bulletin 2024/40

(45) Mention of the grant of the patent:
24.07.2024 Bulletin 2024/30

(21) Application number: 21798059.8

(22) Date of filing: 03.11.2021
(51) International Patent Classification (IPC): 
A23K 20/142(2016.01)
A23K 50/10(2016.01)
 A23K 40/35(2016.01)
(52) Cooperative Patent Classification (CPC):
A23K 40/35; A23K 50/10; A23K 20/142
(86) International application number:
PCT/EP2021/080471
(87) International publication number:
WO 2022/096487 (12.05.2022 Gazette 2022/19)

(54)

COATED COMPOSITIONS OF BIOLOGICALLY ACTIVE INGREDIENTS FOR ORAL ADMINISTRATION TO RUMINANTS

BESCHICHTETE ZUSAMMENSETZUNGEN BIOLOGISCH AKTIVER INHALTSSTOFFE ZUR ORALEN VERABREICHUNG AN WIEDERKÄUER

COMPOSITIONS ENROBÉES D'INGRÉDIENTS BIOLOGIQUEMENT ACTIFS POUR L'ADMINISTRATION ORALE À DES RUMINANTS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 09.11.2020 EP 20206358

(43) Date of publication of application:
13.09.2023 Bulletin 2023/37

(73) Proprietor: Evonik Operations GmbH
45128 Essen (DE)

(72) Inventors:
  • JACKSON, Barry
    Pascagoula, Mississippi 39581 (US)
  • PARYS, Claudia
    35633 Lahnau (DE)
  • RABE, Christian
    63762 Großostheim (DE)
  • BORCHERS, Georg
    61231 Bad Nauheim (DE)
  • GOTTSTEIN, Thomas
    54832 Babenhausen (DE)
  • HEIMBECK, Winfried
    63776 Mömbris (DE)
  • KÖRFER, Martin
    63796 Kahl (DE)

(74) Representative: Evonik Patent Association 
c/o Evonik Industries AG IP Management Bau 1042A/PB 15 Paul-Baumann-Straße 1
45772 Marl
45772 Marl (DE)


(56) References cited: : 
US-A- 5 080 917
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).